This Monitor highlights April KFF Tracking Poll findings on perceptions about measles and explores the unsubstantiated promotion of budesonide and clarithromycin as treatments. It also covers misrepresentations of syringe programs and how prompting strategies can boost the accuracy of AI chatbots on health questions.
In July 2022, “An Arm and a Leg” listener Meagan experienced a bout of vertigo that landed her in the emergency room. For more than two years after, Meagan endured what felt like a never-ending series of communications with the hospital over a medical bill she knew she didn’t owe. Meagan spoke with host Dan…
He’s 17 and lives in the Chicago suburbs. He loves theater and recently helped direct a play at his high school. He takes competitive AP courses and is working on his Eagle Scout project. And he’s been on a journey for four years. Once a week, the transgender teen injects testosterone into his body. He’s…
I was a little surprised that in the days of limitless content, AI, and all types of medical information being online a company could raise $15m to create a platform where actual doctors could answer specific questions that patients might have. Vikram Bhaskaran, the CEO is ex Pinterest and knows the consumer world well. Rohan…
At least according to CEOs from Novartis, Sanofi and AstraZeneca. Reuters reports: European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, the bloc would fall further behind the U.S., where tariff threats have triggered a wave of pharma investment announcements. AstraZeneca Chief Executive Officer Pascal Soriot said…
Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place. The post There’s a Gap Between Healthcare Leaders’ AI Confidence and Their Ability to Scale…
World Class Health’s $10 million raise was led by Transformation Capital. It comes six months after the company secured $8 million in seed funding. The post World Class Health Secures $10M for Global Centers of Excellence Network appeared first on MedCity News.
To inform future directions for PEPFAR and other U.S. global health programs, this policy brief reviews the graduation policies of several institutions to identify options for consideration.
Bristol Myers Squibb’s Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA approved Cobenfy as a standalone schizophrenia treatment. The post Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics appeared first on…
This analysis examines what the Ending the HIV Epidemic (EHE) initiative has done to date and what its future might look like under the second Trump administration.